The Effects of Iron Replacement on Functional Capacity in Patients with Group 1 and Group 4 Pulmonary Hypertension

Akaslan D., Aslanger E., ATAŞ H., Kanar B. G., KOCAKAYA D., YILDIZELİ B., ...Daha Fazla

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.50, sa.7, ss.492-497, 2022 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 7
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5543/tkda.2022.22343
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.492-497
  • Anahtar Kelimeler: Anemia, chronic thromboembolic pulmonary hypertension, ferric carboxymaltose, pulmonary arterial hypertension, pulmonary hypertension, IMPROVES EXERCISE CAPACITY, QUALITY-OF-LIFE, ARTERIAL-HYPERTENSION, DEFICIENCY, THERAPY
  • Marmara Üniversitesi Adresli: Evet

Özet

Objective: Abnormal iron handling complicates pulmonary hypertension and causes functional limitation and poor outcomes. Although preliminary results in group 1 pulmonary hypertension patients support the use of iron replacement, whether this applies to other PH subgroups is not known.